Cardiff City are facing a centre-back shortage for next weekend's League One match against promotion rivals Bolton Wanderers. Bluebirds captain Calum Chambers was taken off at half-time during ...

When Gabriel sent his cancer diary to his son Tristan — a well-known broadcaster and musician — it set something larger in ...

About a decade after he bought a shuttered rare earths mine that was, literally, partially underwater, MP Materials CEO James Litinsky has transformed his business into a pivotal player in America's ...

Last week, President Trump postponed a summit with his Chinese counterpart on account of the war with Iran. When Trump and Xi Jinping do meet, here's an agenda item bound to figure prominently: rare ...

In the middle of the Mojave Desert, just off Interstate 15 between Los Angeles and Las Vegas, sits the Mountain Pass mine. Surrounded by a high plateau of pale rock and desert scrub, this ...

Just as the U.S. faces depletion of the rare earth metals it needs to feed its military machine, REalloys Inc. (NASDAQ: ALOY), one of the key players in rebuilding America’s critical raw materials ...

Ten-man Cardiff’s League One title hopes suffered a further blow as two goals in the space of five minutes late on helped ...

Efforts to develop domestic rare-earth resources are gaining momentum in Texas as policymakers and industry leaders push to reduce U.S. reliance on China for minerals critical to defense and ...

Lynas Rare Earths Ltd. has signed a binding letter of intent to supply the Pentagon with rare-earth oxides over a four-year period. The arrangement is worth $96 million and will cover heavy and light ...

March 10 (Reuters) - Australia's Lynas Rare Earths (LYC.AX), opens new tab has revamped its supply agreement with Japan Australia Rare Earths, securing a firm annual commitment for 5,000 tonnes of ...

REalloys (NASDAQ: ALOY) and a small number of other North American companies are doing what the rest of the Western world failed to do for three decades: They are breaking China’s "kill switch" on the ...

This week’s Capitol Hill meetings come on the heels of rejections of ultra-rare disease drugs developed by Biohaven and Saol Therapeutics. Physicians and patient groups implored the FDA to expedite ...